129 related articles for article (PubMed ID: 8187090)
1. Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis.
Miyake S; Nagai K; Yoshino K; Oto M; Endo M; Yuasa Y
Cancer Res; 1994 Jun; 54(11):3007-10. PubMed ID: 8187090
[TBL] [Abstract][Full Text] [Related]
2. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma.
Hu N; Flaig MJ; Su H; Shou JZ; Roth MJ; Li WJ; Wang C; Goldstein AM; Li G; Emmert-Buck MR; Taylor PR
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6013-22. PubMed ID: 15447985
[TBL] [Abstract][Full Text] [Related]
4. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers.
Huang Y; Boynton RF; Blount PL; Silverstein RJ; Yin J; Tong Y; McDaniel TK; Newkirk C; Resau JH; Sridhara R; Reid BJ; Meltzer SJ
Cancer Res; 1992 Dec; 52(23):6525-30. PubMed ID: 1423299
[TBL] [Abstract][Full Text] [Related]
6. Allelotype analysis of esophageal squamous cell carcinoma.
Shibagaki I; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
Cancer Res; 1994 Jun; 54(11):2996-3000. PubMed ID: 8187088
[TBL] [Abstract][Full Text] [Related]
7. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
[TBL] [Abstract][Full Text] [Related]
8. p16MTS1/CDK4I mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinoma of the larynx.
Jares P; Fernández PL; Nadal A; Cazorla M; Hernández L; Pinyol M; Hernández S; Traserra J; Cardesa A; Campo E
Oncogene; 1997 Sep; 15(12):1445-53. PubMed ID: 9333020
[TBL] [Abstract][Full Text] [Related]
9. DNA aberrations at the retinoblastoma gene locus in human squamous cell carcinomas of the lung.
Sachse R; Murakami Y; Shiraishi M; Hayashi K; Sekiya T
Oncogene; 1994 Jan; 9(1):39-47. PubMed ID: 8302602
[TBL] [Abstract][Full Text] [Related]
10. [Multiple tumor suppressor 1/p16 gene alterations in human esophageal squamous-cell carcinoma: clinical significance and regional difference].
Lü G; Chen X; Cao W
Zhonghua Zhong Liu Za Zhi; 1999 Sep; 21(5):359-62. PubMed ID: 11776574
[TBL] [Abstract][Full Text] [Related]
11. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas.
Gao X; Honn KV; Grignon D; Sakr W; Chen YQ
Cancer Res; 1993 Jun; 53(12):2723-7. PubMed ID: 8504411
[TBL] [Abstract][Full Text] [Related]
12. Frequent allelic deletions and loss of expression characterize the DCC gene in male germ cell tumors.
Murty VV; Li RG; Houldsworth J; Bronson DL; Reuter VE; Bosl GJ; Chaganti RS
Oncogene; 1994 Nov; 9(11):3227-31. PubMed ID: 7936646
[TBL] [Abstract][Full Text] [Related]
13. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the DCC tumor suppressor gene in testicular germ cell tumors: mutations and loss of expression.
Strohmeyer D; Langenhof S; Ackermann R; Hartmann M; Strohmeyer T; Schmidt B
J Urol; 1997 May; 157(5):1973-6. PubMed ID: 9112574
[TBL] [Abstract][Full Text] [Related]
15. Infrequent mutation in the BRCA2 gene in esophageal squamous cell carcinoma.
Hu N; Li G; Li WJ; Wang C; Goldstein AM; Tang ZZ; Roth MJ; Dawsey SM; Huang J; Wang QH; Ding T; Giffen C; Taylor PR; Emmert-Buck MR
Clin Cancer Res; 2002 Apr; 8(4):1121-6. PubMed ID: 11948123
[TBL] [Abstract][Full Text] [Related]
16. The MTS1 gene is frequently mutated in primary human esophageal tumors.
Zhou X; Tarmin L; Yin J; Jiang HY; Suzuki H; Rhyu MG; Abraham JM; Meltzer SJ
Oncogene; 1994 Dec; 9(12):3737-41. PubMed ID: 7970734
[TBL] [Abstract][Full Text] [Related]
17. [Expression and loss of heterozygosity of DCC gene in human lung cancer].
Zhang J; Ding F; Wang X
Zhonghua Yi Xue Za Zhi; 1995 Apr; 75(4):211-3, 254-5. PubMed ID: 7788550
[TBL] [Abstract][Full Text] [Related]
18. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers.
Boynton RF; Huang Y; Blount PL; Reid BJ; Raskind WH; Haggitt RC; Newkirk C; Resau JH; Yin J; McDaniel T; Meltzer SJ
Cancer Res; 1991 Oct; 51(20):5766-9. PubMed ID: 1913694
[TBL] [Abstract][Full Text] [Related]
19. [Loss of heterozygosity involving DCC gene in human colorectal cancers is correlated with the metastatic potential].
Gao S; Xu W; Wan Y
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):250-2. PubMed ID: 9387312
[TBL] [Abstract][Full Text] [Related]
20. The DCC gene: structural analysis and mutations in colorectal carcinomas.
Cho KR; Oliner JD; Simons JW; Hedrick L; Fearon ER; Preisinger AC; Hedge P; Silverman GA; Vogelstein B
Genomics; 1994 Feb; 19(3):525-31. PubMed ID: 8188295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
